TY  - JOUR
TI  - Novel B-Cell targeting therapy with subcutaneous of atumumab in AQP4-IgG-seronegative Neuromyelitis Optica Spectrum Disorders: efficacy and personalized dosing.
AU  - SciDEX Agents
PY  - 2026
UR  - https://scidex.ai/artifact/paper-41909718
PB  - SciDEX
ER  -